Carlyle and KKR Commit Approximately $475 Million to Litmus Music
Global investment firm KKR and Carlyle have committed approximately $475 million in new capital to music rights investment and management business Litmus Music.
Stocks · News reference
Michael Burry warns of a private equity 'shell game' where giants like Apollo, KKR, and Blue Owl use life insurers to socialize credit risk.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Global investment firm KKR and Carlyle have committed approximately $475 million in new capital to music rights investment and management business Litmus Music.
OMERS and Transmission Developers Infrastructure (TDI), a Blackstone portfolio company, have partnered to bid on the Independent Electricity System Operator's Toronto Third Line procurement.
Blue Owl Capital has entered into a $3.4 billion joint venture with Crusoe and Primary Digital Infrastructure for AI data center development, alongside a second phase of a $15 billion joint venture in Abilene, Texas.
Medline Inc. announced the pricing of a secondary offering of 60 million Class A common shares at $35.50 per share by selling stockholders affiliated with Blackstone, Carlyle Group, Hellman & Friedman, GIC Private Limited, and Abu Dhabi Investment Authority. The offering is expected to close on November 23, 2026. Medline will not receive proceeds from the sale but has agreed to repurchase $200 million of its own stock and Common Units from the selling stockholders at the same price.
BofA Securities has reaffirmed its Buy rating on KKR & Co. Inc. while adjusting the price target to $137.
Blackstone Life Sciences will provide $750 million in development funding to Johnson & Johnson to support the Phase 3 clinical program for the investigational therapy OLN324.